Neonatal Multisystem Inflammatory Syndrome (MIS-N) Associated with Prenatal Maternal SARS-CoV-2: A Case Series

Ravindra Pawar, Vijay Gavade, Nivedita Patil, Vijay Mali, Amol Girwalkar, Vyankatesh Tarkasband, Sanjog Loya, Amit Chavan, Narendra Nanivadekar, Rahul Shinde, Uday Patil, Satyan Lakshminrusimha, Ravindra Pawar, Vijay Gavade, Nivedita Patil, Vijay Mali, Amol Girwalkar, Vyankatesh Tarkasband, Sanjog Loya, Amit Chavan, Narendra Nanivadekar, Rahul Shinde, Uday Patil, Satyan Lakshminrusimha

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a post-infectious immune-mediated condition, seen 3-5 weeks after COVID-19. Maternal SARS-CoV-2 may potentially cause a similar hyperinflammatory syndrome in neonates due to transplacental transfer of antibodies. We reviewed the perinatal history, clinical features, and outcomes of 20 neonates with features consistent with MIS-C related to maternal SARS-CoV-2 in Kolhapur, India, from 1 September 2020 to 30 April 2021. Anti-SARS-CoV-2 IgG and IgM antibodies were tested in all neonates. Fifteen singletons and five twins born to eighteen mothers with a history of COVID-19 disease or exposure during pregnancy presented with features consistent with MIS-C during the first 5 days after birth. Nineteen were positive for anti-SARS-CoV-2 IgG and all were negative for IgM antibodies. All mothers were asymptomatic and therefore not tested by RTPCR-SARS-CoV-2 at delivery. Eighteen neonates (90%) had cardiac involvement with prolonged QTc, 2:1 AV block, cardiogenic shock, or coronary dilatation. Other findings included respiratory failure (40%), fever (10%), feeding intolerance (30%), melena (10%), and renal failure (5%). All infants had elevated inflammatory biomarkers and received steroids and IVIG. Two infants died. We speculate that maternal SARS-CoV-2 and transplacental antibodies cause multisystem inflammatory syndrome in neonates (MIS-N). Immunomodulation may be beneficial in some cases, but further studies are needed.

Keywords: COVID-19; anti SARS-CoV-2 antibodies; multisystem inflammatory syndrome in children (MIS-C); neonate.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Various presentations of SARS-CoV-2 infection and its sequences in the neonatal period. Red colored subjects with a ‘+’ sign indicate COVID-19 positive patients. Pregnant mother A has COVID-19 and her baby is negative at birth but contracts late-onset COVID-19 due to transmission from the mother. Pregnant mother B has no COVID-19 but her neonate develops late-onset neonatal infection due to exposure to a family member 2–4 weeks after birth. Pregnant mother C is COVID-19 positive during the perinatal period and transmits the virus to her offspring during birth leading to early-onset infection in the neonate. This baby can potentially develop MIS-C 2–4 weeks later (a rare occurrence) [16]. Pregnant mother D has COVID-19 during pregnancy but the neonate remains healthy. Pregnant mother E has COVID-19 disease or exposure to SARS-COV-2 during pregnancy and the baby develops multisystem inflammation secondary to passive transfer of antibodies leading to MIS-N (multisystem inflammatory syndrome in neonates) [14].
Figure 2
Figure 2
Representative EKGs of neonates presenting with bradycardia. Baby number sequence is the same as in Table 3. The first column showing EKGs at presentation (A,D,G,J,M), with sinus rhythm, prolonged QT interval and atrio-ventricular block. Middle column showing sinus rhythm and prolonged QT interval (B,E,H,K,N). The last column showing sinus rhythm with normal QT interval (C,F,I,L,O). Black arrows = atrial beats; horizontal square bracket = QT interval; QTc = corrected QT interval; ms = milliseconds. QTc values in the figure are derived by the formula QTc = QT/√RR.
Figure 3
Figure 3
Echocardiography and clinical findings in neonates with MIS-C. Baby number sequence is the same as in Table 3. Transthoracic echocardiography, parasternal short axis view in Baby #14 (A) and Baby #19 (B,C). The left main and left anterior descending coronary artery (yellow arrow) and the right coronary artery (blue arrow) are significantly dilated. AV = aortic valve. Transthoracic echocardiography and color doppler, parasternal short axis view in Baby #4 (D), showing aorta (Ao) and main pulmonary artery (MPA) bifurcation, with a large thrombus (red arrow) obstructing the left pulmonary artery (yellow star) origin and causing flow turbulence on color doppler (E), but normal flows across right pulmonary artery (green star). Transthoracic echocardiography subcostal bi-caval view in Baby # 20 (F), showing a thrombus (red arrow) in right atrium (RA). Baby #6, showing oral and muco-cutaneous lesions (G) and, pedal edema and skin peeling (H) and Baby #7 with black, tarry stools (melena, I).

References

    1. WHO COVID-19 Dashboard. [(accessed on 24 June 2021)]; Available online:
    1. Gupta S., Malhotra N., Gupta N., Agrawal S., Ish P. The curious case of coronavirus disease 2019 (COVID-19) in children. J. Pediatr. 2020;222:258–259. doi: 10.1016/j.jpeds.2020.04.062.
    1. Brodin P. Why is COVID-19 so mild in children? Acta Paediatr. 2020;109:1082–1083. doi: 10.1111/apa.15271.
    1. Rawat M., Chandrasekharan P., Hicar M.D., Lakshminrusimha S. COVID-19 in Newborns and Infants-Low Risk of Severe Disease: Silver Lining or Dark Cloud? Am. J. Perinatol. 2020;37:845–849. doi: 10.1055/s-0040-1710512.
    1. Whittaker E., Bamford A., Kenny J., Kaforou M., Jones C.E., Shah P., Ramnarayan P., Fraisse A., Miller O., Davies P., et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA J. Am. Med. Assoc. 2020;324:259–269. doi: 10.1001/jama.2020.10369.
    1. Verdoni L., Mazza A., Gervasoni A., Martelli L., Ruggeri M., Ciuffreda M., Bonanomi E., D’Antiga L. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study. Lancet. 2020;395:1771–1778. doi: 10.1016/S0140-6736(20)31103-X.
    1. Belhadjer Z., Meot M., Bajolle F., Khraiche D., Legendre A., Abakka S., Auriau J., Grimaud M., Oualha M., Beghetti M., et al. Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic. Circulation. 2020;142:429–436. doi: 10.1161/CIRCULATIONAHA.120.048360.
    1. Davies P., Evans C., Kanthimathinathan H.K., Lillie J., Brierley J., Waters G., Johnson M., Griffiths B., du Pre P., Mohammad Z., et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: A multicentre observational study. Lancet Child Adolesc. Health. 2020;4:669–677. doi: 10.1016/S2352-4642(20)30215-7.
    1. Nakra N.A., Blumberg D.A., Herrera-Guerra A., Lakshminrusimha S. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management. Children. 2020;7:69. doi: 10.3390/children7070069.
    1. Consiglio C.R., Cotugno N., Sardh F., Pou C., Amodio D., Rodriguez L., Tan Z., Zicari S., Ruggiero A., Pascucci G.R., et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell. 2020;183:968–981.e7. doi: 10.1016/j.cell.2020.09.016.
    1. Godfred-Cato S., Tsang C.A., Giovanni J., Abrams J., Oster M.E., Lee E.H., Lash M.K., Le Marchand C., Liu C.Y., Newhouse C.N. Multisystem Inflammatory Syndrome in Infants<12 months of Age, United States, May 2020–January 2021. Pediatric Infect. Dis. J. 2021;40:601–605.
    1. Godfred-Cato S., Bryant B., Leung J., Oster M.E., Conklin L., Abrams J., Roguski K., Wallace B., Prezzato E., Koumans E.H., et al. COVID-19-Associated Multisystem Inflammatory Syndrome in Children—United States, March–July 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1074–1080. doi: 10.15585/mmwr.mm6932e2.
    1. McCarty K.L., Tucker M., Lee G., Pandey V. Fetal Inflammatory Response Syndrome Associated With Maternal SARS-CoV-2 Infection. Pediatrics. 2020 doi: 10.1542/peds.2020-010132.
    1. Divekar A.A., Patamasucon P., Benjamin J.S. Presumptive Neonatal Multisystem Inflammatory Syndrome in Children Associated with Coronavirus Disease 2019. Am. J. Perinatol. 2021 doi: 10.1055/s-0041-1726318.
    1. Khaund Borkotoky R., Banerjee Barua P., Paul S.P., Heaton P.A. COVID-19-Related Potential Multisystem Inflammatory Syndrome in Childhood in a Neonate Presenting as Persistent Pulmonary Hypertension of the Newborn. Pediatric Infect. Dis. J. 2021;40:e162–e164. doi: 10.1097/INF.0000000000003054.
    1. Kappanayil M., Balan S., Alawani S., Mohanty S., Leeladharan S.P., Gangadharan S., Jayashankar J.P., Jagadeesan S., Kumar A., Gupta A., et al. Multisystem inflammatory syndrome in a neonate, temporally associated with prenatal exposure to SARS-CoV-2: A case report. Lancet Child Adolesc. Health. 2021;5:304–308. doi: 10.1016/S2352-4642(21)00055-9.
    1. Shaiba L.A., Hadid A., Altirkawi K.A., Bakheet H.M., Alherz A.M., Hussain S.A., Sobaih B.H., Alnemri A.M., Almaghrabi R., Ahmed M., et al. Case Report: Neonatal Multi-System Inflammatory Syndrome Associated With SARS-CoV-2 Exposure in Two Cases From Saudi Arabia. Front. Pediatr. 2021;9:652857. doi: 10.3389/fped.2021.652857.
    1. Clark B.C., Sanchez-de-Toledo J., Bautista-Rodriguez C., Choueiter N., Lara D., Kang H., Mohsin S., Fraisse A., Cesar S., Sattar Shaikh A., et al. Cardiac Abnormalities Seen in Pediatric Patients During the SARS-CoV2 Pandemic: An International Experience. J. Am. Heart Assoc. 2020;9:e018007. doi: 10.1161/JAHA.120.018007.
    1. CDC Information for Healthcare Providers about Multisystem Inflammatory Syndrome in Children (MIS-C) [(accessed on 25 June 2021)]; Available online:
    1. AAP Multisystem Inflammatory Syndrome in Children (MIS-C) Interim Guidance. [(accessed on 25 June 2021)]; Available online:
    1. Chawla D., Chirla D., Dalwai S., Deorari A.K., Ganatra A., Gandhi A., Kabra N.S., Kumar P., Mittal P., Parekh B.J., et al. Perinatal-Neonatal Management of COVID-19 Infection—Guidelines of the Federation of Obstetric and Gynaecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP) Indian Pediatr. 2020;57:536–548. doi: 10.1007/s13312-020-1852-4.
    1. Kobayashi T., Fuse S., Sakamoto N., Mikami M., Ogawa S., Hamaoka K., Arakaki Y., Nakamura T., Nagasawa H., Kato T., et al. A New Z Score Curve of the Coronary Arterial Internal Diameter Using the Lambda-Mu-Sigma Method in a Pediatric Population. J. Am. Soc. Echocardiogr. Off. Publ. Am. Soc. Echocardiogr. 2016;29:794–801.e29. doi: 10.1016/j.echo.2016.03.017.
    1. Alsaleem M. Intravenous Immune Globulin Uses in the Fetus and Neonate: A Review. Antibodies. 2020;9:60. doi: 10.3390/antib9040060.
    1. Navarro M., Negre S., Matoses M.L., Golombek S.G., Vento M. Necrotizing enterocolitis following the use of intravenous immunoglobulin for haemolytic disease of the newborn. Acta Paediatr. 2009;98:1214–1217. doi: 10.1111/j.1651-2227.2009.01279.x.
    1. Whitworth H.B., Sartain S.E., Kumar R., Armstrong K., Ballester L., Betensky M., Cohen C., Diaz R., Diorio C., Goldenberg N.A., et al. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood. 2021 doi: 10.1182/blood.2020010218.
    1. Lakshminrusimha S., Hudak M., Dimitriades V., Higgins R.D. Multisystem Inflammatory Syndrome (MIS-C) in Neonates (MIS-N) Following Maternal SARS CoV-2 COVID-19 Infection. Am. J. Perinatol. 2021 (editorial under review)
    1. Gray K.J., Bordt E.A., Atyeo C., Deriso E., Akinwunmi B., Young N., Medina Baez A., Shook L.L., Cvrk D., James K., et al. COVID-19 vaccine response in pregnant and lactating women: A cohort study. Am. J. Obstet. Gynecol. 2021 doi: 10.1016/j.ajog.2021.03.023.
    1. Kabeerdoss J., Pilania R.K., Karkhele R., Kumar T.S., Danda D., Singh S. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: Immunological mechanisms, clinical manifestations and management. Rheumatol. Int. 2021;41:19–32. doi: 10.1007/s00296-020-04749-4.
    1. Anderson E.M., Diorio C., Goodwin E.C., McNerney K.O., Weirick M.E., Gouma S., Bolton M.J., Arevalo C.P., Chase J., Hicks P., et al. SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19. J. Pediatric. Infect. Dis. Soc. 2020 doi: 10.1093/jpids/piaa161.
    1. Vella L.A., Giles J.R., Baxter A.E., Oldridge D.A., Diorio C., Kuri-Cervantes L., Alanio C., Pampena M.B., Wu J.E., Chen Z., et al. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Sci. Immunol. 2021;6 doi: 10.1126/sciimmunol.abf7570.
    1. Gruber C.N., Patel R.S., Trachtman R., Lepow L., Amanat F., Krammer F., Wilson K.M., Onel K., Geanon D., Tuballes K., et al. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) Cell. 2020;183:982–995.14. doi: 10.1016/j.cell.2020.09.034.
    1. Zeng H., Xu C., Fan J., Tang Y., Deng Q., Zhang W., Long X. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia. JAMA J. Am. Med. Assoc. 2020 doi: 10.1001/jama.2020.4861.
    1. Flannery D.D., Gouma S., Dhudasia M.B., Mukhopadhyay S., Pfeifer M.R., Woodford E.C., Triebwasser J.E., Gerber J.S., Morris J.S., Weirick M.E., et al. Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios. JAMA Pediatr. 2021 doi: 10.1001/jamapediatrics.2021.0038.
    1. Atyeo C., Pullen K.M., Bordt E.A., Fischinger S., Burke J., Michell A., Slein M.D., Loos C., Shook L.L., Boatin A.A., et al. Compromised SARS-CoV-2-specific placental antibody transfer. Cell. 2021;184:628–642.e10. doi: 10.1016/j.cell.2020.12.027.
    1. Blumberg D., Sridhar A., Lakshminrusimha S., Higgins R.D., Saade G. COVID-19 Vaccine Considerations during Pregnancy and Lactation. Am. J. Perinatol. 2021;38:523–528. doi: 10.1055/s-0041-1726390.
    1. Shimabukuro T.T., Kim S.Y., Myers T.R., Moro P.L., Oduyebo T., Panagiotakopoulos L., Marquez P.L., Olson C.K., Liu R., Chang K.T., et al. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N. Engl. J. Med. 2021 doi: 10.1056/NEJMoa2104983.
    1. Metz T.D., Clifton R.G., Hughes B.L., Sandoval G., Saade G.R., Grobman W.A., Manuck T.A., Miodovnik M., Sowles A., Clark K., et al. Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19) Obstet. Gynecol. 2021;137:571–580. doi: 10.1097/AOG.0000000000004339.

Source: PubMed

3
Subscribe